Prostate cancer awareness 5k schlep

I didn't find out about it until after it occurred on Saturday 1/29, but there was a 5k "schlep" (their choice of word, not mine) in Santa Barbara, to raise awareness of breast, ovarian and prostate cancers. In the past, I've heard rumblings of discontent about how PC wasn't given the same coverage as breast cancer, so I interpreted this as a positive sign.

Prostate cancer gets much less attention from the advocacy community than does, for instance, breast cancer. Men tend to take a less active role in advocating for our own health care and disease prevention and treatment. In America the squeaky wheel gets the oil. At least, those have been my observations in my lifetime.
I just read a very interesting new article published 1/26/23 over at Medscape on PCa data. The American Cancer Society CEO reported that since 2011, the diagnosis of advanced-stage (regional- or distant-stage) prostate cancer has increased by 4%–5% annually and the proportion of men diagnosed with distant-stage disease has doubled. Some say that this was, in part, a result of some policy driving panel of so-called policy "medical experts" recommending reduced use of PSA testing as a diagnostic indicator. ACS says that men diagnosed with prostate cancer from 2014-19 rose by 15%. Some claim those stated percentages are very conservative and likely significantly higher.
Moreover, ACS spent $25.3 million on breast cancer research and $6.7 million for prostate cancer in 2018, and in 2023 will designate $126.5 for breast cancer research and $43.9 million for prostate cancer, when the number of annual diagnoses and deaths are comparable for both disease states.
So start complaining to your congress critters and support Pca advocacy groups who lobby on our behalf for a bigger piece of the research pie. Maybe then we'll see more 5k runs for prostate cancer pop up in our locales.